OCUL Stock | | | USD 9.77 0.12 1.21% |
The current 90-days correlation between Ocular Therapeutix and Centessa Pharmaceuticals PLC is 0.32 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ocular Therapeutix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ocular Therapeutix moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Ocular Therapeutix Correlation With Market
Very weak diversification
The correlation between Ocular Therapeutix and DJI is 0.4 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ocular Therapeutix and DJI in the same portfolio, assuming nothing else is changed.
Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocular Therapeutix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in employment.
For more information on how to buy Ocular Stock please use our
How to buy in Ocular Stock guide.
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations | | High negative correlations |
Risk-Adjusted IndicatorsThere is a big difference between Ocular Stock performing well and Ocular Therapeutix Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ocular Therapeutix's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.